Millennium Management’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $60.8M | Buy |
204,846
+173,395
| +551% | +$56.1M | 0.03% | 712 |
|
|
2025
Q4 | $9.56M | Buy |
31,451
+13,602
| +76% | +$4.45M | ﹤0.01% | 2319 |
|
|
2025
Q3 | $6.08M | Sell |
17,849
-183,506
| -91% | -$55.7M | ﹤0.01% | 2927 |
|
|
2025
Q2 | $48.7M | Buy |
201,355
+14,445
| +8% | +$3.54M | 0.02% | 831 |
|
|
2025
Q1 | $50.9M | Buy |
186,910
+41,147
| +28% | +$9.62M | 0.03% | 758 |
|
|
2024
Q4 | $26.9M | Buy |
145,763
+88,638
| +155% | +$18.1M | 0.01% | 1278 |
|
|
2024
Q3 | $12.8M | Buy |
57,125
+43,342
| +314% | +$7.8M | 0.01% | 1970 |
|
|
2024
Q2 | $1.97M | Buy |
13,783
+9,063
| +192% | +$1.4M | ﹤0.01% | 3549 |
|
|
2024
Q1 | $738K | Sell |
4,720
-2,604
| -36% | -$419K | ﹤0.01% | 4545 |
|
|
2023
Q4 | $1.32M | Sell |
7,324
-39,783
| -84% | -$7.2M | ﹤0.01% | 3937 |
|
|
2023
Q3 | $8.47M | Sell |
47,107
-63,864
| -58% | -$12.6M | ﹤0.01% | 2205 |
|
|
2023
Q2 | $19.8M | Buy |
110,971
+33,253
| +43% | +$7.66M | 0.01% | 1401 |
|
|
2023
Q1 | $16.8M | Buy |
77,718
+46,155
| +146% | +$11.1M | 0.01% | 1479 |
|
|
2022
Q4 | $6.94M | Sell |
31,563
-16,825
| -35% | -$3.09M | ﹤0.01% | 2514 |
|
|
2022
Q3 | $6.52M | Buy |
48,388
+12,160
| +34% | +$2.09M | ﹤0.01% | 2641 |
|
|
2022
Q2 | $5.86M | Buy |
+36,228
| New | +$5.66M | ﹤0.01% | 2630 |
|
|
2022
Q1 | – | Sell |
-2,447
| Closed | -$520K | – | 7607 |
|
|
2021
Q4 | $663K | Buy |
2,447
+626
| +34% | +$211K | ﹤0.01% | 4792 |
|
|
2021
Q3 | $661K | Sell |
1,821
-2,419
| -57% | -$791K | ﹤0.01% | 5081 |
|
|
2021
Q2 | $1.46M | Buy |
+4,240
| New | +$1.4M | ﹤0.01% | 4298 |
|
|
2021
Q1 | – | Sell |
-23,997
| Closed | -$6.2M | – | 6594 |
|
|
2020
Q4 | $6.2M | Buy |
+23,997
| New | +$6.61M | ﹤0.01% | 2235 |
|
|
2020
Q1 | – | Sell |
-70,906
| Closed | -$11.1M | – | 4612 |
|
|
2019
Q4 | $11.8M | Buy |
+70,906
| New | +$11.8M | 0.01% | 1249 |
|
|
2019
Q3 | – | Sell |
-35,385
| Closed | -$4.7M | – | 4622 |
|
|
2019
Q2 | $4.39M | Buy |
35,385
+15,417
| +77% | +$1.96M | 0.01% | 1880 |
|
|
2019
Q1 | $2.64M | Buy |
19,968
+13,276
| +198% | +$1.79M | ﹤0.01% | 2221 |
|
|
2018
Q4 | $939K | Buy |
6,692
+1,073
| +19% | +$142K | ﹤0.01% | 2611 |
|
|
2018
Q3 | $968K | Sell |
5,619
-126,520
| -96% | -$21.3M | ﹤0.01% | 2890 |
|
|
2018
Q2 | $20.3M | Buy |
+132,139
| New | +$23.6M | 0.03% | 843 |
|
|
2017
Q4 | – | Sell |
-3,454
| Closed | -$357K | – | 4130 |
|
|
2017
Q3 | $357K | Buy |
+3,454
| New | +$257K | ﹤0.01% | 2992 |
|
|
2017
Q2 | – | Sell |
-14,061
| Closed | -$515K | – | 3940 |
|
|
2017
Q1 | $515K | Sell |
14,061
-86,168
| -86% | -$3.14M | ﹤0.01% | 2803 |
|
|
2016
Q4 | $3.04M | Buy |
+100,229
| New | +$3.15M | 0.01% | 1645 |
|
|
2016
Q3 | – | Sell |
-20,684
| Closed | -$616K | – | 3682 |
|
|
2016
Q2 | $616K | Sell |
20,684
-43,403
| -68% | -$1.27M | ﹤0.01% | 2386 |
|
|
2016
Q1 | $1.88M | Buy |
+64,087
| New | +$1.82M | ﹤0.01% | 1809 |
|
Other funds holding ONC
BBA
HA
Millennium Management's ONC Position: Q1 2026 in Review
Millennium Management increased its BeOne Medicines Ltd (ONC) stake by 551% in Q1 2026, buying an estimated $56.1M and bringing the position to 204,846 shares worth $60.8M. The position accounts for 0.03% of the portfolio, ranked #712.
Millennium Management first reported a position in ONC in Q1 2016 and has held it in 31 quarters since. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.
- Millennium Management held 204,846 shares of BeOne Medicines Ltd worth $60.8M as of Q1 2026.
- Millennium Management bought 173,395 BeOne Medicines Ltd shares in Q1 2026, an estimated $56.1M.
- BeOne Medicines Ltd made up 0.03% of Millennium Management's portfolio in Q1 2026, its #712 holding.
- Millennium Management first reported a position in BeOne Medicines Ltd in Q1 2016 and has held it in 31 quarters since.
- 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.